Hedge fund manager John Paulson rakes in $45.3 million in a gold trade


There's nothing like a quick profit. Hedge fund manager, John Paulson, made $45.3 million in five weeks in a single gold trade. Bloomberg reports he owns 10.3 million shares of Detour Gold (DRGDF). Since purchasing the shares in October, they soared 35% to close at CAD $18 per share in Toronto.

Paulson, who manages $30 billion, has invested heavily in several gold companies. He is the largest shareholder of Anglo Gold Ashanti Ltd. (AU) with 12% of the company's stock. He also has stakes in Kinross Gold Corp (KGC) and Gold Fields Ltd. (GFI).

Paulson has ridden the wave of a strong bull move in gold. Gold has risen 34% this year. In addition, Paulson's ability to purchase a controlling interest in a company like Detour Gold virtually ensures against bear raids on his position. This leaves the buyers with a free ride on the upside.

If you want to speculate in gold shares, Paulson says that Gabriel Resources (GBRRF) could triple if the company opens a gold mine in Romania.

Paulson intends to open a gold fund next year.

Symbol Lookup
IndexesChangePrice
DJIA+46.3210,387.01
NASDAQ+19.982,228.87
S&P 500+7.031,098.87

Last updated: September 09, 2010: 03:02 AM

Hot Stocks

General Electric

15.70+0.26(+1.68)

Alcoa

11.07+0.21(+1.93)

Apple Inc

262.92+5.11(+1.98)

Google Inc 'A'

470.58+6.18(+1.33)

Bank of America

13.37+0.16(+1.21)

Wal-Mart Stores

51.83-0.03(-0.06)

Exxon Mobil Corp

60.75+0.20(+0.33)

Ford

11.800.00(0.00)

Citigroup

3.84+0.01(+0.26)

IBM

126.08+0.13(+0.10)

Yahoo

13.75+0.22(+1.63)

Starbucks

24.78-0.09(-0.36)

Microsoft

23.93-0.03(-0.13)

Home Depot

29.45+0.12(+0.41)

DailyFinance Headlines

Benzinga Headlines

TheFlyOnTheWall.com Headlines

    BioHealth Investor Headlines

    WalletPop Headlines

    DailyFinance BlackBerry App

    My Portfolios

    Track your stocks here!

    Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

    BloggingStocks Partners

    More from AOL Money & Finance

    BioHealth Investor Headlines